New hope for kids with severe bleeding disorder: Extended-Release treatment tested
NCT ID NCT05147662
Summary
This study tested the safety of a longer-lasting clotting factor injection called BAY94-9027 (Jivi) in children aged 7 to under 12 with severe hemophilia A. The treatment is designed to prevent and control bleeding episodes with fewer injections than standard therapies. Researchers monitored 36 children for allergic reactions and treatment effectiveness over 24 months to ensure the medicine works safely in this younger age group.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMOPHILIA A are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Acibadem Adana Hastanesi, Çocuk Sagligi ve Hastaliklari, Çocuk Hematoloji-Onkoloji Bölümü
Adana, 01130, Turkey (Türkiye)
-
Akdeniz Üniversitesi Tip Fakültesi Çocuk Sagligi ve Hastaliklari Anabilim Dali Çocuk Hematoloji ve Onkoloji Bilim Dali
Antalya, 07059, Turkey (Türkiye)
-
Arnold Palmer Hospital for Children
Orlando, Florida, 32806, United States
-
Ege Üniversitesi Tip Fakültesi, Çocuk Sagligi ve Hastaliklari Anabilim Dali, Çocuk Hematoloji Bilim Dali
Izmir, 35100, Turkey (Türkiye)
-
Gaziantep Üniversitesi Tip Fakültesi, Sahinbey Arastirma Ve Uygulama Hastanesi, Çocuk Hematoloji ve Onkoloji Bilim Dali
Gaziantep, 27100, Turkey (Türkiye)
-
HEMORIO
Rio de Janeiro, Rio de Janeiro, 20211-030, Brazil
-
Hacettepe Üniversitesi Tip Fakültesi, Hacettepe Ihsan Dogramaci Çocuk Hastanesi,
Ankara, 06230, Turkey (Türkiye)
-
Hosp Clínicas Facult. Med. de Ribeirão Preto / USP
Ribeirão Preto, São Paulo, 14051-140, Brazil
-
Hospital das Clínicas de Campinas - UNICAMP
Campinas, São Paulo, 13083-878, Brazil
-
Hospital de Niños Sor María Ludovica
La Plata, Buenos Aires, 1900, Argentina
-
Instituo Hematología Arbesú
Godoy Cruz, Mendoza Province, 5501, Argentina
-
Instituto de Hematología Dr. Rubén Dávoli
Rosario, Santa Fe Province, S2000CKF, Argentina
-
Irmandadade da Santa Casa de Misericordia de Sao Paulo (iSANTACASA)
São Paulo, São Paulo, 01223-001, Brazil
-
McMaster Children's Hospital
Hamilton, Ontario, L8N 3Z5, Canada
-
OUS Rikshospitalet Klinisk Forskningspost Barn
Oslo, 372, Norway
-
Ondokuz Mayis Üniversitesi Tip Fakültesi, Saglik Uygulama ve Arastirma Merkezi, Çocuk Sagligi ve Hastaliklari Anabilim Dali
Samsun, 55200, Turkey (Türkiye)
-
Ospedale Pediatrico Bambino Gesù - Oncoematologia, Trapianto Emopoietico e Terapie Cellulari
Roma (RM), Lazio, 00165, Italy
Conditions
Explore the condition pages connected to this study.